跳至主要内容
临床试验/CTRI/2026/02/102772
CTRI/2026/02/102772尚未招募不适用

A Comparative Clinical Trial To Evaluate The Efficacy of Guduchi Tail Matrabasti As Add On Therapy With Antigout Drug In Gout.

DIPALI KUNDALWAL1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2026年2月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
To decrease the uric acid level in gout after giving Guduchi Tail Matrabasti with Antigout Drug allopurinol for 15 days

研究概览

简要总结

This is a clinical trial to evaluate the Efficacy of Guduchi Tail Matrabasti as add on therapy with Antigout Drug in gout with the help of subjective and objective cliteria and specific test with the help of case record form

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Age:20 – 65years.
  • Sex:Both male and female.
  • Socio Economic status: All
  • Patients of Gout presenting features as per text such as swelling, pain, stiffness, tenderness, Discolouration of skin.

排除标准

  • Age below 20 and above 65 years.
  • Arthropathy other than Gout.Leprosy,SLE,Sarvang shoth,TB,Renal disease.
  • Pregnancy and lactating mother.

结局指标

主要结局

To decrease the uric acid level in gout after giving Guduchi Tail Matrabasti with Antigout Drug allopurinol for 15 days

时间窗: 0th day before trial, 15th day after trial and 30th day on day of follow up

次要结局

未报告次要终点

研究者

发起方
DIPALI KUNDALWAL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DIPALI ARVIND KUNDALWAL

Assistant professor

研究点 (1)

Loading locations...

相似试验

It is a Comparative Clinical study To Evaluate The... | 临床试验